Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2

被引:48
作者
Tanimura, Y
Kokuryo, T
Tsunoda, N
Yamazaki, Y
Oda, K
Nimura, Y
Mon, NN
Huang, PY
Nakanuma, Y
Chen, MF
Jan, YY
Yeh, TS
Chiu, CT
Hsieh, LL
Hamaguchi, M
机构
[1] Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan
[3] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208641, Japan
[4] Chang Gumg Univ, Mem Hosp, Dept Surg, Taipei 105, Taiwan
[5] Chang Gumg Univ, Mem Hosp, Dept Gastroenterol, Taipei 105, Taiwan
[6] Chang Gumg Univ, Mem Hosp, Dept Publ Hlth, Taipei 105, Taiwan
关键词
cholangiocarcinoma; matrix metalloproteinase; tumor necrosis factor-alpha; invasion;
D O I
10.1016/j.canlet.2004.07.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied the effect of TNF-alpha stimulation on a cholangiocarcinoma cell line, CCKS1. CCKS1 expressed only one type TNF receptor,TNFR2. Treatment of CCKS1 with TNF-a substantially activated NF kappa B, MAPK and Akt signalings which in turn activated matrix metalloproteinase-9 (MMP-9) secretion and in vitro invasiveness of CCKS1. Pretreatment of cells with anti-TNFR2 neutralizing antibody inhibited the TNF-alpha-dependent signaling and MMP-9 secretion and subsequently blocked invasion in vitro. Moreover, an inhibitor for matrix metalloproteinase, Galardin, suppressed the invasion in a dose-dependent manner. Similarly, pharmacological inhibition of signaling clearly suppressed the TNF-alpha dependent MMP-9 secretion. These results strongly suggest that TNF-alpha-TNFR2 signaling plays an important role to convert the cholangiocarcinoma cells to be more aggressive one. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 32 条
[1]  
Amin ARMR, 2003, CANCER RES, V63, P6334
[2]   Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1β:: a role for the dual signalling pathways, Akt and Erk [J].
Amin, ARMR ;
Senga, T ;
Oo, ML ;
Thant, AA ;
Hamaguchi, M .
GENES TO CELLS, 2003, 8 (06) :515-523
[3]   A role for SHPS-1/SIRPα1 in IL-1β- and TNFα-dependent signaling [J].
Amin, ARMR ;
Machida, K ;
Oshima, K ;
Oo, ML ;
Thant, AA ;
Senga, T ;
Matsuda, S ;
Akhand, AA ;
Maeda, A ;
Kurosaki, T ;
Hamaguchi, M .
ONCOGENE, 2002, 21 (57) :8871-8877
[4]   Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development [J].
Arnott, CH ;
Scott, KA ;
Moore, RJ ;
Robinson, SC ;
Thompson, RG ;
Balkwill, FR .
ONCOGENE, 2004, 23 (10) :1902-1910
[5]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[6]   Signal transduction by tumor necrosis factor and its relatives [J].
Baud, V ;
Karin, M .
TRENDS IN CELL BIOLOGY, 2001, 11 (09) :372-377
[7]  
Chainy GBN, 1996, J IMMUNOL, V157, P2410
[8]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[9]   α-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases [J].
Dudich, E ;
Semenkova, L ;
Dudich, I ;
Gorbatova, E ;
Tochtamisheva, N ;
Tatulov, E ;
Nikolaeva, M ;
Sukhikh, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (03) :750-761
[10]  
GRELL M, 1994, J IMMUNOL, V153, P1963